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Summary
Rhabdomyolysis, literally meaning the breakdown
of muscle tissue, is a common syndrome with many
causes, acquired ones such as exertion, trauma, in-
fections, temperature extremes, drugs, toxins, elec-
trolyte and endocrine abnormalities, and congenital
ones such as myopathies and connective tissue
disorders. All results in a common pathophysiologic
pathway which ends with the dispersing of muscle
tissue content into the circulation. Rhabdomyolysis
has characteristic clinical, laboratory and radiologic
features, but does require a high index of suspicion
so that the diagnosis would not be missed. The sen-
sitivity and specificity of the various characteristics,
as well as clinical guidelines, are discussed in this
paper. The syndrome may present with several
complications, e.g. arrhythmias, electrolyte abnor-
malities, acute renal injury, acidosis, volume deple-
tion, compartment syndrome and disseminated in-
travascular coagulation. The prognosis is highly
variable and depends on the underlying etiologies
and complications, but is in general considered as
good. The milestone of treatment is vigorous fluid
resuscitation. Treatment options, in practice and in
research, are discussed in the following pages.
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Introduction
Rhabdomyolysis is a syndrome characterized by
breakdown of muscle tissue, followed by dispersing
its intracellular components into the circulatory sys-
tem. These components include electrolytes, purines,
enzymes (such as creatine kinase) and myoglobin.
This syndrome is associated with many diseases,
drugs, medications, toxins and injuries. The syn-
drome may be expressed as elevated levels of blood
creating phosphokinase (CK) and leading to acute
kidney injury and death. Rhabdomyolysis was first re-
ported in Germany in 1881, but the syndrome was
characterized in detail by Bywaters and Beall during
the Battle of London in the 2nd World War. It is sug-
gested that during the exodus from ancient Egypt, the
bible describes a "plague" characterized as similar to
rhabdomyolysis among the people of Israel, due to
quail consumption, thus intoxication of hemlock herbs
consumed by the quail1. 
Pathophysiology
There are many causes for rhabdomyolysis, but they
seem to lead to a final common feature, which is the
breakdown of muscle tissue, destruction of the my-
ocyte and distribution of its components into the cir-
culatory system. In the normal myocyte, a low level of
Calcium is maintained by a Ca2+ ATPase pump (con-
centrating intracellular Calcium in the sarcoplasmic
reticulum and mitochondria), and a Na/Ca exchanger
ion channel, powered by Sodium influx, due to the
gradient created by the Na/K ATPase pump. All these
mechanisms depend, directly or indirectly on ATP as
a source of energy. The lack of ATP causes the cell's
homeostasis to collapse, causing the intracellular lev-
el of Calcium to rise. In turn, the rise of Calcium level
activates intracellular proteolytic enzymes, thereby
degrading the myocyte. As the cell breaks down,
large quantities of Potassium, aldolase, phosphate,
myoglobin, CK, lactate dehydrogenase (LDH), aspar-
tate transferase (AST) and urate leak into the circula-
tion2. When more than 100g of muscle tissue is de-
graded the plasma's myoglobin binding capacity is
overwhelmed and free myoglobin causes renal mor-
bidity by several mechanisms3-5.
Causes
There is a large variety of causes for rhabdomyolysis,
all leading to muscle ischemia and cell breakdown.
The most common among adult populations are mus-
cle exertion illicit drugs, alcohol abuse, medications,
muscle diseases, trauma, Neuroleptic Malignant Syn-
drome (NMS), seizures and immobility6. Among pedi-
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atric patients, the most common are exertion, viral
myositis, trauma, connective tissue diseases and
drug overdose7.
Excessive muscular activity
Sporadic strenuous exercise, especially in trained
people (e.g. marathon runners, military recruits)8,9, or
involuntary muscle exercise such as seizures10, status
epilepticus, acute psychosis11, status dystonicus12 or
status asthmaticus13 may result in acute severe rhab-
domyolysis. The mechanism is ATP supply-demand
disconcordance, leading to inability to maintain mem-
brane homeostasis. The more strenuous or prolonged
the exercise is, the more damage is incurred14. 
Factors increasing the risk of exertional rhabdomyoly-
sis are hypokalemia (often resulting from excessive
sweating), sickle-cell trait (especially in combination
with high altitude)15, extreme heat and humidity9, ex-
ercise-induced asthma, or pre-exertion fatigue. Low
intensity exercise induced rhabdomyolysis cases
have also been reported, but the mechanism remains
unknown16 .
Electrolyte and endocrine abnormalities
Severe electrolyte abnormalities disrupt the cell's
membrane homeostasis, mainly by disturbing the
Na/K ATPase pump. Hyponatremia17, hypernatrem-
ia18, hypokalemia19 and hypophosphatemia (usually
as part of diabetic ketoacidosis)20 may result in rhab-
domyolysis. It has been suggested that extreme ex-
ercise with intense fluid consumption by athletes may
cause hyponatremia induced rhabdomyolysis21. Poly-
dypsia alone can initiate dilutional hyponatremia fol-
lowed by rhabdomyolysis as well22. Hypokalemia in-
duced rhabdomyolysis was reported as a complica-
tion of hyperaldesteronism or pseudoaldestero-
nism23, laxatives24, liquorice ingestion25 and many
other etiologies.
Endocrine abnormalities such as hyperaldostero-
nism26,27, Addison's disease28, hypothyroidism29, hy-
perthyroidism30, diabetic ketoacidosis20,31, non-ketotic
hyperosmolar state32 have been reported occasional-
ly to cause rhabdomyolysis.
Temperature extremes
Excessive heat caused by heat stroke33,34, malignant
hyperthermia syndrome35 and neuroleptic malignant
syndrome36,37 may result in muscle damage, on the
cellular level. A body core temperature of 42°C
(107.6°F) for 45 minutes to 8 hours was established
to be the thermal maximum, meaning the level and
duration of heat that muscle cells can endure without
being damaged38. The higher the heat a body will ab-
sorb, cellular destruction will occur at a higher and
faster extent39. Malignant hyperthermia is a condition
usually ascribed as a genetic susceptibility to anes-
thetic drugs, causing hyperthermia, increased meta-
bolic rate, elevated respiratory rate, pulse, rigidity
and rhabdomyolysis. It may also be triggered by exer-
cise (exercise induced malignant hyperpyrexia)40. In
neuroleptic malignant syndrome, the mechanism sug-
gested is that neuroleptic medications induce abnor-
mal calcium availability in muscle cells of susceptible
individuals and trigger muscle rigidity, rhabdomyoly-
sis and hyperthermia37.
Although rare, rhabdomyolysis might be induced by
exposure to extreme cold (with or without hypother-
mia), due to direct muscle injury41,42.
Both temperature extremes could be facilitated by ex-
posure and activity during voluntary exercise and ex-
ertion. 
Muscle ischemia
Muscle ischemia means deprivation of oxygen from
muscle tissue, resulting in decreased levels of ATP
production. Prolonged ischemia may lead to muscle
cells necrosis. Ischemia may be caused by a general
condition, such as shock, hypotension, CO intoxica-
tion43 and sickle cell trait15. Alternatively, it may be a
result of a localized specific cause, such as blood
vessel thrombosis, embolism, compartment syn-
drome44, or compression of a vessel (e.g. surgical
tourniquets45, tight dressings or casts and vessel
clamping46,47). Prolonged immobilization, mainly due
to substance or alcohol abuse, coma or anesthesia,
is a major cause of compression of blood vessels.
Like trauma, pathophysiology actually takes place
once pressure is relieved from the damaged tissue,
and the necrotic muscles release their components
into circulation48. Known positions resulting in rhab-
domyolysis are lateral decubitus, lithotomy, sitting,
knee-to-chest, prone position49 and harness hang-
ing50. Overweight >30% of ideal body mass, surgery
of more than 5-6 hours, circulatory volume depletion
and pre-existing diabetes or hypertension are con-
tributing risk factors51.
Drugs
Rhabdomyolysis may result from substance abuse, pre-
scription and nonprescription medications. Substances
that are commonly abused include ethanol, methanol
and ethylene glycol52,53, heroin, methado ne54, tobacco,
cocaine, amphetamine, 3,4-methylenedioxymetham-
phetamine (MDMA, ecstasy), phencyclidine55, lysergic
acid diethylamide (LSD)56, benzodiazepines57, barbitu-
rates58 and toluene (from glue sniffing)59. 
Alcohol can induce rhabdomyolysis through a combi-
nation of mechanisms including immobilization with
muscle compression (due to immobilization), direct
myotoxicity (due to inhibition of calcium accumulation
by the sarcoplasmic reticulum and alteration of mem-
brane viscosity with derangement of membrane ion
transporters), aberration in myocyte carbohydrate
metabolism, dehydration and electrolyte abnormali-
ties (hypokalemia and hypophosphatemia)55,60. Co-
caine induced rhabdomyolysis is caused by either va-
sospasm with muscular ischemia, hyperpyrexia,
seizures, coma with muscle compression or direct
myofibrillar damage55. Drug and alcohol abusers are
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often malnourished, with resultant diminished glyco-
gen storage and ATP reserve.
Excessive use of barbiturates, benzodiazepines and
other sedative and hypnotic drugs causes depression
of the central nervous system with prolonged immobi-
lization and muscle compression, resulting in hypox-
ia, suffering and destruction58.
Rhabdomyolysis may also result from both prescribed
and over-the-counter medications including salicy-
lates61, statins (e.g., simvastatin, lovastatin, pravas-
tatin, rosuvastatin, cerivastatin)62-65, especially sim-
vastatin, statin-fibrate combination66, theophylline67,
cyclic antidepressants, selective serotonin reuptake
inhibitors68,69, phenylpropanolamine containing diet
pills70, fibric acid derivatives (e.g., bezafibrate, clofi-
brate, fenofibrate, gemfibrozil)71,72, neuroleptics73,
anesthetic (e.g. propofol)74 and paralytic agents (the
malignant hyperthermia syndrome)75, quinine76, ana-
bolic steroids77,78, corticosteroids79. Several mecha-
nisms were related to statin induced rhabdomyolysis.
Since cholesterol is an important building block of the
cell's membrane, and its synthesis is blocked, the re-
sult is also unstable skeletal muscle cell membrane.
In addition, mitochondrial respiratory function is inter-
rupted due to coenzyme Q10 deficiency. A third
mechanism is the presence of abnormal prenylated
proteins which causes an imbalance in intracellular
signal transduction80.
Toxins
Toxin induced rhabdomyolysis include carbon monox-
ide (CO)43, snake bites81, spider venom82, massive
honey bee and wasps envomination83,84 and quail
eating (it nourishes from hemlock herbs)1. CO gas
has a higher affinity to hemoglobin than oxygen, thus
combining with it to form carboxyhemoglobin in the
blood, preventing the binding of oxygen, causing
muscle hypoxia and rhabdomyolysis.
Trauma
Rhabdomyolysis may occur due to traumatic events,
such as blunt trauma, crush injury, electrical injury or
third degree burns.
Blunt trauma may be due to direct blow or motor-ve-
hicle crush (including acceleration-deceleration
mechanism). Crush injuries are associated with mass
casualty events and severe trauma, such as terror at-
tacks, bombing, earthquakes and building collapses,
train accidents and mining accidents. For instance,
earthquakes result in 3% to 20% of crush injuries, of
which 74% involve the lower extremity85. The rhab-
domyolysis pathophysiology actually takes place
once pressure is relieved from the damaged tissue,
and the necrotic muscles release their components
into circulation48, for example, once people are ex-
tracted from a crushed vehicle. High voltage electrical
injury, caused by lightning strike or high voltage pow-
er supply, or extensive third degree burns results in
rhabdomyolysis due to direct myofibrillar damage86.
However, extensive thermal third degree burns could
also result in rhabdomyolysis. Regardless of the ini-
tial cause, late onset Rhabdomyolysis could occur
due to immobilization or circumferential burns con-
tractures. The treatment of burn induced rhabdomyol-
ysis presents a great challenge because burn treat-
ment itself requires vigorous fluid overload, thus mak-
ing it difficult to add more fluids for rhabdomyolysis
management86.
Infections
Several mechanisms are ascribed to infection in-
duced rhabdomyolysis: bacterial invasion of a mus-
cle, low energy related enzymatic activity, tissue hy-
poxia (due to sepsis, general hypoxia, acidosis, dehy-
dration and electrolyte disturbances)87, high lysoso-
mal enzymatic activity88 and endotoxins89.
Numerous bacterial, viral, fungal and protozoal infec-
tions can lead to rhabdomyolysis. Viral infections as a
cause of rhabdomyolysis have been described in
many reports worldwide, of which influenza types A
(including recent reports of H1N1 subtype)90,91 and B
are the most common92. Other viral infections induc-
ing rhabdomyolysis include HIV, Coxsackievirus, Ep-
stein-Barr virus, Echovirus, Cytomegalovirus, Aden-
ovirus, Herpes simplex virus, Parainfluenza, Varicel-
la-Zoster virus92 and West Nile virus93. Bacterial in-
fections are often associated with rhabdomyolysis in
adults, most commonly Legionella. Other species de-
scribed as associated with rhabdomyolysis are Strep-
tococcus pneumoniae, Staphylococcus aureus,
Streptococcus viridans, Salmonella species, Staphy-
lococcus epidermidis, Francisella tularensis, Strepto-
coccus faecalis, Meningococci, Hemophilus influen-
za, E.coli, Pseudomonas, Klebsiella, Enterococcus
faecalis, Bacteroides94, group B streptococcus, Strep-
tococcus pyogenes, Listeria species, Vibrio species,
Leptospira species95, Brucella species, Bacillus
species and Clostridium species92.
Myositis and associated rhabdomyolysis has also
been reported in patients with fungal or parasitic in-
fections, especially among immunocompromised pa-
tients96, the most notable being malaria97,98.
Myopathies
Genetic disorders leading to rhabdomyolysis are ei-
ther inherited myopathies (e.g. Duchene muscular dy-
strophy and Becker's dystrophy)99, metabolic en-
zymes deficiencies (restricting carbohydrate or lipid
metabolism)100,101 or mitochondrial function disor-
ders102. Usually, these disorders will present them-
selves in early childhood. Careful history taken may
reveal these etiologies. Muscle dystrophies were sus-
pected to predispose malignant hyperthermia but rel-
ative risk was found to be insignificant103. Connective
tissue disorders inducing rhabdomyolysis are rare,
but have been described. They include polymyositis,
dermatomyositis104 and inclusive body myositis. In-
flammatory myopathy can present with very high CK
levels, but not as high as those found in muscle dys-
trophies101 (Tab.1).
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Clinical Presentation
Because of the many possible causes, there is a vari-
ety of rhabdomyolysis' presentations. It may be se-
vere when substantial muscle damage has occurred,
or, vice versa, subclinical, when the damage is minor.
A classic triad was described inclusive of muscle
aches, weakness and dark, tea colored urine. Espe-
cially when accompanied by clues of muscle damage,
this should raise the suspicion of Rhabdomyolysis.
This is especially true in pediatrics105. Some more
specific symptoms include muscle tenderness,
swelling, cramping, stiffness, weakness and loss of
function of the relevant muscles. The most common
muscle groups involved are postural muscles, such
as lower back, thighs and calves. Muscle swelling
might not be apparent until after intravenous (IV) flu-
ids rehydration. Other symptoms may be of non spe-
cific nature, such as fever, malaise, abdominal pain,
nausea and vomiting. Change of mental status may
occur due to the underlying cause (e.g., trauma, tox-
ins or drugs, infections, electrolyte abnormality, or
urea induced encephalopathy).
Physical examination might reveal limb induration or
skin changes due to ischemic damage of involved tis-
sues (e.g. blisters, discoloration). However, there
may be no signs of muscle involvement.
Rhabdomyolysis could be an incidental finding of a
laboratory test. Anyhow, purposeful efforts should be
made to identify an underlying cause.
Work-Up
A high index of suspicion is crucial for diagnosing
rhabdomyolysis, since classic presentation such as
muscular swelling, pain and tenderness may not be
eminent, or even be absent. A thorough history must
be taken. The definitive diagnosis is made by labora-
tory tests including serum CK and urine myoglobin. A
skeletal muscle biopsy can be used to establish the
diagnosis, but is not obligatory.
Serum CK (Creatine Kinase)
Serum CK concentration, mainly the CK-MM subtype,
is the most sensitive indicator of damage to muscles.
Serum CK begins to rise approximately 2 to 12 hours
after the onset of muscle injury, peaks within 24 to 72
hours, and then declines gradually in 7-10 days. A
persistently elevated CK level suggests continuing
muscle injury, development of a compartment syn-
drome or continuing muscle stress (e.g. prolonged
exercise or infection)2. Currently, there is not a clear-
ly agreed level of serum CK that is evident for diag-
nosis of rhabdomyolysis. However, a CK level higher
than 5 times of its normal value is accepted by many
authors as diagnostic criteria. Moreover, some stud-
ies establish the low specificity of serum CK levels.
Kenney et al. found in their contingent of 499 young
healthy recruits a CK elevation of 10 times that re-
garded as normal, none diagnosed as exertional
rhabdomyolysis, and suggesting either coexisting
myoglobinuria or CK level of 50 folds of normal as a
diagnostic threshold106. Statin induced rhabdomyoly-
sis is commonly defined with marked CK elevation
greater than 10 times the upper limit of normality,
with muscle symptoms and usually with brown urine
with myoglobinuria65.
Serum and urine myoglobin
Myoglobin is normally bound to plasma globulins, and
is maintained at a low serum level of 0 to 0.003mg/dL3.
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Table 1. Causes for rhabdomyolysis (by mechanism).
1. Increased energy demand:
1.1 Exercise (especially strenuous exercise)
1.2 Heat stroke
1.3 Acute psychosis
1.4 Seizures; Status epilepticus
1.5 Status dystonicus
1.6 Status asthmaticus
1.7 Delirium tremens
2. Decreased energy production
2.1 Dystrophies
2.2 Metabolic enzyme deficiencies
2.3 Mitochondrial function disorders
2.4 Hypokalemia
2.5 Hypophosphatemia
3. Direct muscle injury
3.1 Crush injury (trauma)
3.2 Electrical injury
3.3 3rd degree burns
3.4 Inflammatory myopathy
3.5 Temperature extremes (hyper/hypothermia)
3.6 Hyper/hyponatremia
4. Decreased oxygen delivery
4.1 Arterial thrombus; emboli
4.2 Surgery; prolonged immobilization
4.3 Trauma
4.4 Shock
4.5 Sickle cell trait/crisis
5. Infections:
5.1 Viral
5.2 Bacterial
5.3 Fungal
6. Endocrine abnormalities:
6.1 Diabetic keto-acidosis; non-ketotic hyperosmolar 
state
6.2 Addison's disease
6.3 Hyperaldosteronism
6.4 Hypo/hyperthyroidism
7. Drugs & medications:
7.1 Substance abuse (MDMA, Amphetamine, Heroin,
Methadone, Cocaine, PCP, LSD)
7.2 Alcohol; ethylene glycol
7.3 Sedative/hypnotic drugs (Barbiturates, 
Benzodiazepines)
7.4 Anesthetics (malignant hyperthermia)
7.5 Statins; Fibrates
7.6 Neuroleptics
7.7 Anabolic/corticosteroids
8. Toxins:
8.1 Carbon mono-oxide (CO)
8.2 Venom – snake; spider; bee; wasp
8.3. Quail eating
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Once circulating myoglobin levels have exceeded 0.5
to 1.5mg/dL it overwhelms its protein binding capacity,
tubule endocytosis rate and metabolism rate, and is
rapidly excreted in the urine107. Note that myoglobolin-
uria is pathognomonic to rhabdomyolysis, but is not
necessarily visible. Elevated serum myoglobin and
myoglobinuria are reliable indicators for rhabdomyoly-
sis, but present some limitations. Serum myoglobin
levels rise and drop much faster than CK levels (in 1 to
6 hours), thus have a low negative predictive value
and may not be used as a ruling out test. Secondly,
myoglobolinuria is not always visible, or may be re-
solved early; it takes a urine myoglobin level of
100mg/dL to cause tea or cola colored urine. More-
over, detecting myoglobinuria is commonly done using
urine dipstick tests (ortho-toluidine), which also react
with the globin fragment of hemoglobin, thus a non-
specific test (e.g. in hematuria due to erythrocytes or
their fragments). Rodríguez-Capote et al. performed a
systemic review which proved a high sensitivity but
poor specificity of myoglobinuria as a rhabdomyolysis
marker108. Immunoassay is more sensitive and specific
than dipstick, but often not readily available, and it may
take days to obtain results. Thus, serum myoglobin
and myoglobinuria are not necessarily sensitive or
specific parameters, dependant on many factors. 
Imaging
Rhabdomyolysis is usually diagnosed as a clinical syn-
drome, with supporting laboratory tests. However, re-
cent reports claim that, in obscure cases, in which diag-
nosis is not definite, several imaging tests may prove
useful. Bone scintography demonstrates Tc99-labeled
diphosphonate reacting with released calcium (due to
sarcolemmal disruption) in muscle tissue109. Magnetic
resonance imaging (MRI) may demonstrate an in-
creased signal using T2 weighted images, a decreased
signal using T1 weighted images, and a contrast be-
tween healthy and damaged muscles using STIR im-
ages (which suppresses fat tissue signal). Computer-
ized tomography (CT) images demonstrate diffuse ar-
eas of low attenuation in the muscle and muscular
swelling due to edema and defined intramuscular hypo-
dense foci suggesting muscle necrosis. Ultra sound
(US) may reveal hypoechoic areas attributed to inflam-
mation and fluid infiltration110,111. All techniques could
also detect macroscopic findings of the kidney, if affect-
ed. None of these techniques is highly specific to rhab-
domyolysis, but MRI has proved to be almost 100%
sensitive, as other modalities were inferior112.
Often rhabdomyolysis is not diffuse, but is isolated to
a specific muscle group. In these cases bone scintog-
raphy or preferably MRI could demonstrate the affect-
ed muscles113, and serve as a decision making tool,
when fasciotomy is considered110,114, to avoid unnec-
essary interventions. 
Investigations for underlying cause
Diagnosing rhabdomyolysis must be followed by a
search for the cause. A careful history and physical
examination are crucial, but may not always help in
concluding definitively the underlining etiology. In
such cases there is not a clear protocol for which
tests should be attempted. If drugs or toxins are sus-
pected, toxicological screening should be done. If in-
fection is a possibility, appropriate cultures, complete
blood count (CBC) and serological studies should be
performed. If an endocrine or a metabolic disorder is
suspected, blood chemistry and endocrine assay is to
be done to confirm this.
Furthermore, in young patients or in recurrent ER, ge-
netic analysis115, muscle biopsy102 and the forearm
ischemic exercise test116 (revealing myopathies and
metabolic disorders) may be indicated, since suspi-
cion of genetic disorders should arise. The suscepti-
bility of any individual to malignant hyperthermia can
be detected by performing the caffeine halothane
contracture test (CHCT), although currently genetic
tests may diagnose it without the need for this inva-
sive procedure117. Magnetic resonance imaging (MRI)
had also been proved useful in distinguishing the var-
ious etiologies of Rhabdomyolysis.
Other investigations
ECG monitoring is essential to detect cardiac arrhyth-
mias related to hyperkalemia or hypocalcemia118. Elec-
trolyte abnormalities related to rhabdomyolysis (e.g.
hyperkalemia, hypocalcemia, hyperphosphatemia, hy-
peruricemia) may be detected using a simple blood
chemistry test. Metabolic acidosis could be detected
using arterial blood gas analysis. Raised levels of mus-
cle enzymes such as lactate dehydrogenase (LDH), al-
dolase, carbonic anhydrase III and aminotransferases
(particularly aspartate aminotransferase – AST with
normal levels of alanine aminotransferase - ALT) can
indicate the occurrence of rhabdomyolysis. Elevated
levels of troponin subtype I are found in 50% of rhab-
domyolysis cases, while it is normal in inflammatory
and chronic myopathies, in which troponin T subtype
and CK levels are elevated2. In rhabdomyolysis asso-
ciated kidney injury, the elevation in serum creatinine
is often more rapid compared to other causes of kid-
ney injury, especially among muscular young people.
In concordance, the blood urea nitrogen (BUN) to cre-
atinine ratio is typically low4. 
Due to all that, CBC, blood chemistry, liver and kid-
ney function tests, prothrombin time (PT), activated
partial thromboplastin time (aPTT), may be useful
laboratory tests and should be considered.
Complications
Arrhythmias may occur due to electrolytes abnor-
malities, chiefly hyperkalemia and hypocalcemia.
Since both abnormalities, as well as others de-
scribed, can present themselves very early in the
pathogenesis involving rhabdomyolysis, especially
hypocalcemia of the early phase4, monitoring and
early intervention are indicated in order to prevent ar-
rhythmias and cardiac arrest.
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Volume depletion is caused by third spacing of in-
travascular fluid - an influx into muscle tissue, caused
by cellular electrolyte abnormalities. Alternatively, this
could be caused by crush injury, due to external and
internal bleedings. This process facilitates the deple-
tion of available ATP, creating a viscous circle, result-
ing in further damage, hypovolemia and even hypov-
olemic shock. The hypovolemia in extensive rhab-
domyolysis is comparable to that occurring in patients
with major vessel bleeding or with extensive burns
(>60% of body surface)48.
Compartment syndrome is caused by the same fac-
tors as volume depletion, defined as increased intra-
compartmental pressure, causing oxygen deprivation
of the muscle. The syndrome presents with muscle
pain (occasionally out of proportion to observed in-
jury), weakness, parasthesia or hypoesthesia, pallor
and tightness of affected muscles. Note that compart-
ment syndrome may present in a milder manner,
when concerning a non-acute occurrence, such as
chronic exertional compartment syndrome. A com-
partmental pressure of over 30mmHg (which can be
measured using several invasive applications) for
more than 8 hours may cause muscular necrosis, or
higher pressures for lesser time may cause perma-
nent neuromuscular damage, meaning future dys-
function of the musculoskeletal systems, contrac-
tures, posture and gait disturbances119. 
Acute kidney injury (AKI) is very common among
Rhabdomyolysis patients, although sometimes it pre-
sents only several days after the initial impact. About
one third to one half of rhabdomyolysis patients will
develop acute kidney injury120, as 7-10% of all occur-
ing acute kidney injury are due to rhabdomyolysis4.
The mechanisms are diverse and not fully under-
stood. Firstly, myoglobin has a direct nephrotoxic ef-
fect due to its activity as peroxidase-like enzyme,
causing uncontrolled oxidation of biomolecules, lipid
peroxidation and generation of isoprostanes. The
nephrotoxic effect, as cellular damage, is caused also
by the unbalanced conversion of the ferrous oxide
(Fe2+) of the heme group into ferric oxide (Fe3+), gen-
erating hydroxyl radicals121. Secondly, renal vasocon-
striction is caused by renin-angiotensin, vasopressin
and sympathetic innervation, activated due to deple-
tion of intravascular volume. Other inflammatory fac-
tors such as endothelin-1, thorboxane A2 and TNF-α,
and the depletion of nitric oxide also contribute to re-
nal vasoconstriction. Thirdly, myoglobin interacting
with Tamm-Horsfall protein creates casts (more vigor-
ously in an acidic environment), obstructing the tubu-
li, along with sloughed destroyed cells from tubular
necrosis3-5,120.
Acidosis is chiefly caused by the depletion of oxygen
from involved tissues, resulting in lactic acidosis.
However, the kidney injury most probably will advance
the situation rapidly48. Another mechanism is unmoni-
tored usage of loop diuretics122. Acidosis may also be
caused directly or secondarily by many of the drugs
which cause rhabdomyolysis, as mentioned earlier123.
Disseminated intravascular coagulation (DIC) may
be initiated by released components of necrotic mus-
cle tissue, resulting in diffuse internal hemorrhagic
complications39.
Treatment & Management
Although there are no sufficient level I evidence stud-
ies, meaning randomized controlled trials, regarding
management of rhabdomyolysis patients, there are
many series of retrospective clinical studies, case re-
ports and animal models. The milestones of treatment
are vigorous fluid resuscitation, elimination of the un-
derlying cause and prevention of complications.
Prehospital care
Due to hypovolemia and the danger of acute kidney
injury AKI, aggressive fluid resuscitation is required.
Using a large caliber catheter, infusion of 1.5L/hr of
normal saline is needed, in purpose to maintain a pro-
duction of 200 to 300mL of urine per hour. No Lactate
or Potassium containing fluids should be used, due to
the risk of Rhabdomyolysis related hyperkalemia or
lactic acidosis. Early fluid resuscitation, once a single
limb is accessed (e.g. before extraction of the patient
from a crushed vehicle, rubble etc. in case of crush in-
jury)48, definitely prior to evacuation to a medical cen-
ter124, or up to 6 hours after admission125 is reported
to reduce the incidence of AKI. The longer rehydration
is delayed, the more likely is AKI to develop126,127. In
massive crush disasters, several series showed better
results (meaning decreased risk that renal replace-
ment therapy will be required in the future) when intra-
venous rehydration was applied prior to complete ex-
traction of injured patient from the scene, using some-
times only one available limb122,124.
Hospital care
While starting or continuing fluid resuscitation, thor-
ough history and physical examination are needed to
identify and manage the underlining disease. Vital
signs, urine output and serum electrolytes and CK lev-
els should be monitored continuously, using intensive
care monitoring if needed. A urinary catheter should
be inserted and urine output should be monitored
carefully. In patients prone to heart condition due to
preexisting disease or elderly patients, haemodynamic
monitoring might be necessary to avoid fluid overload. 
The chief objective of treatment is to achieve vigor-
ous diuresis and to dilute the toxic products, using
aggressive IV rehydration. A 1.5L/hr infusion of nor-
mal saline is required for initial resuscitation, followed
by 300 to 500mL/hr once hemodynamic stability had
been achieved. Aggressive rehydration is needed es-
pecially when concerning crush injury for hypov-
olemia management, administrating both normal
saline and blood products. The goals set are urine
output greater than 200mL/hr and serum CK levels
lower than 1000U/L. Note that the CK level desired is
not agreed on by all protocols, and that its serum lev-
el will rise only 2-4 hours after the primary injury.
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Adding mannitol and bicarbonate with saline hydra-
tion is advised in order to prevent acute kidney injury,
although yet to be supported by randomized con-
trolled trials. Sodium bicarbonate is used for urinary
alkalization, reducing the nephrotoxic affect of myo-
globin, cast obstruction, hyperkalemia and lipid per-
oxidation4,124. Administration is carried out with either
one ampoule (44meq) diluted in 1L of half normal
saline or 2-3 ampoules (88-132meq) in 1L of 5% dex-
trose. A rate of 100mL/hr is recommended in order to
maintain urine PH>6.5122. During treatment, serum bi-
carbonate, calcium and potassium levels should be
monitored, along with urine PH. If symptomatic
hypocalcemia develops, or urine PH resists treatment
for more than 6 hours, alkalization should be discon-
tinued. In case of iatrogenic metabolic alkalosis
(serum PH>7,45), caused by sodium bicarbonate, Ac-
etalozamide administration might prove useful, as it
enhances urine alkalization122.
Mannitol is suggested to increase renal blood flow
and glomerular filtration rate, which helps in prevent-
ing obstruction of tubuli by myoglobin casts. Another
benefit of osmotic diuresis is the drawing of interstitial
fluid back to the intravascular compartment, improv-
ing hypovolemia, muscle swelling and nerve com-
pression. It also reduces free radicals' level4. Manni-
tol is to be administrated as 20% infusion, giving a
loading dose of 0.5g/kg during a 15 minute period,
followed by 0.1g/kg/hr infusion rate. Nevertheless,
mannitol is to be administered only once intravascular
volume had been restored. It should be avoided with
patients with oliguria. Urinary and serum pH levels
should be monitored, with acetazolamide added if the
serum pH is >7.45 or urinary pH remains lower than
6.039. However, there are no randomized controlled
studies that prove the yield of mannitol in this sce-
nario, and some studies have found no benefit128. It
should be considered in light of the risk for osmotic
nephrosis, due to renal vasoconstriction and tubular
toxicity when mannitol serum level exceeds
1000mg/dL129. During treatment, plasma osmolality
and osmolal gap (the difference between measured
and calculated serum osmolality) should be moni-
tored, with mannitol discontinued if sufficient diuresis
is not achieved, or serum osmolal gap exceeds
55mOsm/kg (equals to 1000mg/dL serum level)4,129.
The use of loop diuretics (e.g.,furosemide) or recom-
binant B-natriuretic peptide (Neseritide) in Rhab-
domyolysis is controversial, with some researchers
recommending their use and others opposing it, be-
cause loop diuretics acidify the urine and as there is
not sufficient evidence of their yield in reducing mor-
tality, reducing the need for dialysis, reducing the
number of dialysis sessions applied and shortening
the time of hospitalization130. However, since it acidi-
fies the urine, it might prove useful in cases of iatro-
genic metabolic acidosis caused by excessive use of
normal saline infusions131. 
It has been suggested that treatment with corticos-
teroids might reduce secondary muscle damage due
the inflammatory response following initial muscle
damage132. 
Treatment of any reversible cause of muscle dam-
age
The objective is to stop any progressing muscle de-
struction. Any toxin, infection, trauma or hyperthermia
must be diagnosed and treated as early as possible.
Drugs and toxins should be eliminated and detoxified
(e.g. gastric lavage, antidotes and/or hemodialysis) if
possible, and hypoxia must be corrected. Infections
should be treated using a broad spectrum antimicro-
bial regimen until isolated and diagnosed; surgical
eradication of infectious foci should be considered
(e.g. abscess drainage, soft tissue debridement or re-
moval of infected foreign body). Muscle compartment
syndrome is to be treated with fasciotomy. Hyperther-
mia is treated with external cooling measures and
benzodiazepines to control muscular hyperactivity. In
malignant hyperthermia, anesthetics should be dis-
continued, and the patient should be treated with
dantrolene sodium; the usual initial dose is 2.5-4.0
mg/kg, followed by a maintenance dose of 1 mg/kg
every four hours for up to 48 hours to avoid reoccur-
rence of the disease39. Electrolyte and metabolic ab-
normalities that cause rhabdomyolysis (e.g., hypona-
tremia, hypernatremia, hyperglycemia, hypocalcemia,
and hypophosphatemia) should be corrected as soon
as possible. 
Prognosis
The prognosis of Rhabdomyolysis is heavily depen-
dent upon the underlying etiology, and the associat-
ed comorbidities. Despite the lack of any well-orga-
nized prospective studies, the available evidence
from case reports and small retrospective studies
suggests that rhabdomyolysis, when treated early
and aggressively, has an excellent prognosis. More-
over, the prognosis for the recovery of full renal func-
tion is also excellent.
References
1. Rizzi D, Basile C, Di Maggio A, et al. Clinical spectrum of acci-
dental hemlock poisoning: neurotoxic manifestations, rhab-
domyolysis and acute tubular necrosis. Nephrol Dial Trans-
plant 1991; 6(12): 939-943.
2. Brancaccio P, Lippi G, Maffulli N. Biochemical markers of mus-
cular damage. Clin Chem Lab Med 2010; 48(6):757-767.
3. Hendgen-Cotta UB, Flögel U, Kelm M, Rassaf T. Unmasking
the Janus face of myoglobin in health and disease. J Exp Biol
2010; 213(Pt 16): 2734-2740.
4. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney
injury. N Engl J Med 2009; 361(1):62-72.
5. Plotnikov EY, Chupyrkina AA, Pevzner IB, Isaev NK, Zorov
DB. Myoglobin causes oxidative stress, increase of NO pro-
duction and dysfunction of kidney's mitochondria. Biochim Bio-
phys Acta 2009; 1792(8):796-803.
6. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: an eval-
uation of 475 hospitalized patients. Medicine (Baltimore) 2005;
84(6): 377-385.
7. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhab-
domyolysis: causes and rates of renal failure. Pediatrics 2006;
118(5): 2119-2125.
Muscles, Ligaments and Tendons Journal 2013; 3 (4): 303-312 309
Rhabdomyolysis. The role of diagnostic and prognostic factors
©
 C
IC
 Ed
izi
o
i I
nt
rn
zio
na
li
8. Alpers JP, Jones LK, Jr. Natural history of exertional rhab-
domyolysis: a population-based analysis. Muscle Nerve 2010;
42(4): 487-491.
9. Landau ME, Kenney K, Deuster P, Campbell W. Exertional
rhabdomyolysis: a clinical review with a focus on genetic influ-
ences. J Clin Neuromuscul Dis 2012; 13(3):122-136.
10. Gupta P, Singh VP, Chatterjee S, Agarwal AK. Acute renal fail-
ure resulting from rhabdomyolysis following a seizure. Singa-
pore Med J 2010; 51(4): e79-80.
11. Coryell W, Norby LH, Cohen LH. Psychosis-induced rhab-
domyolysis. Lancet 1978; 2(8085): 381-382.
12. Manji H, Howard RS, Miller DH, et al. Status dystonicus: the
syndrome and its management. Brain 1998; 121: 243-252.
13. Carroll CL, Zucker AR. The increased cost of complications in
children with status asthmaticus. Pediatr Pulmonol 2007;
42(10): 914-919.
14. Patel DR., Gyamfi R, Torres A. Exertional rhabdomyolysis and
acute kidney injury. Phys Sportsmed 2009; 37(1):71-79.
15. Makaryus JN, Catanzaro JN, Katona KC. Exertional rhabdomy-
olysis and renal failure in patients with sickle cell trait: is it time to
change our approach? Hematology 2007; 12(4):349-352.
16. Gagliano M, Corona D, Giuffrida G. Low-intensity body build-
ing exercise induced rhabdomyolysis: a case report. Cases J
2009; 2(1):7.
17. Trimarchi H, Gonzalez J, Olivero J. Hyponatremia-associated
rhabdomyolysis. Nephron 1999; 82(3):274-277.
18. Denman JP. Hypernatraemia and rhabdomyolysis. Medical
Journal of Australia 2007; 187(9):527-528.
19. von Vigier RO, Ortisi MT, La Manna A, Bianchetti MG, Bettinelli
A. Hypokalemic rhabdomyolysis in congenital tubular disor-
ders: a case series and a systematic review. Pediatr Nephrol
2010; 25(5): 861-866.
20. Kutlu AO, Kara C, Cetinkaya S. Rhabdomyolysis without de-
tectable myoglobulinuria due to severe hypophosphatemia in
diabetic ketoacidosis. Pediatr Emerg Care 2011; 27(6):537-
538.
21. Siegel AJ. Exercise-associated hyponatremia: role of cy-
tokines. Am J Med 2006; 119 (7 Suppl 1): S74-78.
22. Strachan P, Prisco D, Multz AS. Recurrent rhabdomyolysis as-
sociated with polydipsia-induced hyponatremia - a case report
and review of the literature. Gen Hosp Psychiatry 2007;
29(2):172-174.
23. Goto A, Takahashi Y, Kishimoto M, et al. Primary aldostero-
nism associated with severe rhabdomyolysis due to profound
hypokalemia. Intern Med 2009; 48(4):219-223.
24. Merante A, Gareri P, Marigliano NM, et al. Laxative-induced
rhabdomyolysis. Clin Interv Aging 2010; 5: 71-73.
25. Templin C, Westhoff-Bleck M, Ghadri JR. Hypokalemic paral-
ysis with rhabdomyolysis and arterial hypertension caused by
liquorice ingestion. Clin Res Cardiol 2009; 98(2):130-132.
26. Martínez JJ, Oliveira CL, Meneses AL, Rodríguez SA, Cor-
rales PP, López AH, Romero FB. Rhabdomyolysis due to pri-
mary hyperaldosteronism. Endocrinol Nutr 2009; 56(8): 431-
434.
27. Karagüzel G, Bahat E, Imamoğlu M, Ahmetoğlu A, Yildiz K,
Okten A. An unusual case of an aldosterone-producing
adrenocortical adenoma presenting with rhabdomyolysis. J
Pediatr Endocrinol Metab 2009; 22(11):1087-1090.
28. Solter M, Planinc D, Gabrić I, Katalinic D, Vucicević Z. Severe
rhabdomyolysis as a first symptom in Addison's disease. J En-
docrinol Invest 2010; 33(3):206-207.
29. Barahona MJ, Mauri A, Sucunza N, Paredes R, Wägner AM.
Hypothyroidism as a cause of rhabdomyolysis. Endocr J 2002;
49(6):621-623.
30. Lichtstein DM, Arteaga RB. Rhabdomyolysis associated with
hyperthyroidism. Am J Med Sci 2006; 332(2):103-105.
31. Casteels K, Beckers D, Wouters C, Van Geet C. Rhabdomyoly-
sis in diabetic ketoacidosis. Pediatr Diabetes 2003; 4(1):29-31.
32. Stunkard ME, Pikul VT, Foley K. Hyperosmolar hyperglycemic
syndrome with rhabdomyolysis. Clin Lab Sci 2011; 24(1):8-13.
33. Yeo TP. Heat stroke: a comprehensive review. AACN Clin Is-
sues 2004; 15(2): 280-293.
34. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;
346(25):1978-1988.
35. 35. Elster EA, Harrison J, Stasiewicz SD, Wang D, Golocovsky
M. Malignant hyperthermia in an adult trauma patient. Am
Surg 2002; 68(10):883-885.
36. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hy-
perthermia and muscle rigidity: a practical approach. Eur J
Emerg Med 2003; 10(2):149-154.
37. Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant
syndrome. Br J Anaesth 2000; 85(1):129-135.
38. Bynum GD, Pandolf KB, Schuette WH, et al. Induced hyper-
thermia in sedated humans and the concept of critical thermal
maximum. Am J Physiol 1978; 235(5):R228-236.
39. Khan FY. Rhabdomyolysis: a review of the literature. Neth J
Med 2009; 67(9): 272-283.
40. Brukner P. Clinical Sports Medicine, ed. C. Pike. 2008: Nicole
Meehan.
41. Lim ST, Sohn MH, Jeong HJ. Cold exposure-induced rhab-
domyolysis demonstrated by bone scintigraphy. Clin Nucl Med
2008; 33(5):349-350.
42. Yama N, Koito K, Fujimori K, ert al. Technetium Tc 99m meth-
ylene diphosphonate bone scintigraphy of rhabdomyolysis af-
ter near-drowning in cold seawater. Am J Emerg Med 2007;
25(7):848-850.
43. Sungur M, Guven M. Rhabdomyolysis due to carbon monox-
ide poisoning. Clinical Nephrology 2001; 55(4):336-337.
44. Rudolph T, Lokebo JE, Andreassen L. Bilateral gluteal com-
partment syndrome and severe rhabdomyolysis after lumbar
spine surgery. Eur Spine J 2011; 20 Suppl 2:S180-182.
45. Lee YG, Park W, Kim SH, Yun SP, Jeong H, Kim HJ, Yang DH.
A case of rhabdomyolysis associated with use of a pneumatic
tourniquet during arthroscopic knee surgery. Korean J Intern
Med 2010; 25(1):105-109.
46. Hauser J, Lehnhardt M, Steinau HU, Homann HH.Trocar in-
jury of the retroperitoneal vessels followed by life-threatening
postischemic compartment syndrome of both lower extremi-
ties. Surg Laparosc Endosc Percutan Tech 2008; 18(2):222-
224.
47. Anthony DG, Diaz J, Allen Bashour C, Moon D, Soltesz E. Oc-
cult rhabdomyolysis after acute type A aortic dissection. Crit
Care Med 2011; 39(8):1992-1994.
48. Better OS, Abassi ZA. Early fluid resuscitation in patients with
rhabdomyolysis. Nat Rev Nephrol 2011; 7(7):416-422.
49. Szewczyk D, Ovadia P, Abdullah F, Rabinovici R. Pressure-in-
duced rhabdomyolysis and acute renal failure. J Trauma 1998;
44(2):384-388.
50. Mortimer RB. Risks and management of prolonged suspen-
sion in an Alpine harness. Wilderness Environ Med 2011;
22(1):77-86.
51. Torres-Villalobos G, Kimura E, Mosqueda JL, García-García
E, Domínguez-Cherit G, Herrera MF. Pressure-induced rhab-
domyolysis after bariatric surgery. Obes Surg 2003; 13(2):297-
301.
52. Daher Ede F, Silva Júnior GB, Brunetta DM, Pontes LB, Bez-
erra GP. Rhabdomyolysis and acute renal failure after strenu-
ous exercise and alcohol abuse: case report and literature re-
view. Sao Paulo Med J 2005; 123(1):33-37.
53. Bessa O Jr. Alcoholic rhabdomyolysis: a review. Conn Med
1995;59(9):519-521.
54. Kosmadakis G, Michail O, Filiopoulos V, Papadopoulou P,
Michail S. Acute kidney injury due to rhabdomyolysis in narcotic
drug users. Int J Artif Organs 2011; 34(7):584-588.
55. Richards JR. Rhabdomyolysis and drugs of abuse. J Emerg
Med 2000; 19(1):51-56.
Muscles, Ligaments and Tendons Journal 2013; 3 (4): 303-312310
E. Keltz et al.
©
 C
IC
 Ed
izi
on
i I
nt
er
az
ion
ali
56. Berrens Z, Lammers J, White C. Rhabdomyolysis After LSD
Ingestion. Psychosomatics 2010; 51(4):356-356 e3.
57. Hung CF, Huang TY, Lin PY. Hypothermia and rhabdomyoly-
sis following olanzapine injection in an adolescent with schizo-
phreniform disorder. Gen Hosp Psychiatry 2009; 31(4):376-
378.
58. Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse
and the kidney. QJM 2000; 93(3):147-152.
59. Karmakar GC, Roxburgh R. Rhabdomyolysis in a glue sniffer.
N Z Med J 2008; 121(1271):70-71.
60. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis.
J Am Soc Nephrol 2000; 11(8):1553-1561.
61. Montgomery H, Porter JC, Bradley RD. Salicylate intoxication
causing a severe systemic inflammatory response and rhab-
domyolysis. Am J Emerg Med 1994; 12(5):531-532.
62. Escobar C, Echarri R, Barrios V. Relative safety profiles of high
dose statin regimens. Vasc Health Risk Manag 2008; 4(3):
525-533.
63. Fernandez G, Spatz ES, Jablecki C, Phillips PS. Statin my-
opathy: a common dilemma not reflected in clinical trials. Cleve
Clin J Med 2011; 78(6):393-403.
64. Lefkovitz A, Zarowitz B. Focus on statin safety concerns. Geri-
atr Nurs 2011; 32(5):357-360.
65. Tomaszewski M, Stępień KM, Tomaszewska J, Czuczwar SJ.
Statin-induced myopathies. Pharmacol Rep 2011; 63(4): 859-
866.
66. Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A.
Incidence of hospitalized rhabdomyolysis with statin and fi-
brate use in an insured US population. Ann Pharmacother
2011; 45(10):1230-1239.
67. Tsai J, Chern TL, Hu SC, Lee CH, Wang RB, Deng JF. The
clinical implication of theophylline intoxication in the Emer-
gency Department. Hum Exp Toxicol 1994; 13(10): 651-657.
68. Flanagan RJ. Fatal toxicity of drugs used in psychiatry. Hum
Psychopharmacol, 2008; 23 Suppl 1: 43-51.
69. Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobe-
mide and fluoxetine overdose. Chang Gung Med J 2011;
34(6): 644-649.
70. Rumpf KW, Kaiser HF, Horstkotte H, Bahlmann J. Rhabdomy-
olysis after ingestion of an appetite suppressant. JAMA 1983;
250(16): 2112.
71. Smals AG, Beex LV, Kloppenborg PW. Clofibrate-induced
muscle damage with myoglobinuria and cardiomyopathy. N
Engl J Med 1977; 296(16): 942.
72. Tahmaz M, Kumbasar B, Ergen K, Ure U, Karatemiz G,
Kazancioglu R.  Acute renal failure secondary to fenofibrate
monotherapy-induced rhabdomyolysis. Ren Fail 2007; 29(7):
927-930.
73. Dickmann JR, Dickmann LM. An uncommonly recognized
cause of rhabdomyolysis after quetiapine intoxication. Am J
Emerg Med 2010; 28(9): 1060 e1-2.
74. Fudickar A, Bein B. Propofol infusion syndrome: update of clin-
ical manifestation and pathophysiology. Minerva Anestesiol
2009; 75(5):339-344.
75. Capacchione JF, Muldoon SM. The relationship between ex-
ertional heat illness, exertional rhabdomyolysis, and malignant
hyperthermia. Anesth Analg 2009; 109(4):1065-1069.
76. Lim AK, Ho L, Levidiotis V. Quinine-induced renal failure as a
result of rhabdomyolysis, haemolytic uraemic syndrome and
disseminated intravascular coagulation. Intern Med J 2006;
36(7): 465-467.
77. Farkash U, Shabshin N, Pritsch Perry M. Rhabdomyolysis of
the deltoid muscle in a bodybuilder using anabolic-androgenic
steroids: a case report. J Athl Train, 2009; 44(1): 98-100.
78. Hughes M, Ahmed S. Anabolic androgenic steroid induced
necrotising myopathy. Rheumatol Int 2011; 31(7):915-917.
79. Gayan-Ramirez G, Decramer M. The effect of corticotherapy
on respiratory muscles. Rev Mal Respir 1998; 15(1): 33-41.
80. Khan FY, Ibrahim W. Rosuvastatin induced rhabdomyolysis in
a low risk patient: a case report and review of the literature.
Curr Clin Pharmacol 2009; 4(1):1-3.
81. Cheng AC, Currie BJ. Venomous snakebites worldwide with a
focus on the Australia-Pacific region: current management and
controversies. J Intensive Care Med 2004; 19(5): 259-269.
82. Cohen J, Bush S. Case report: compartment syndrome after a
suspected black widow spider bite. Ann Emerg Med 2005;
45(4): 414-416.
83. Mathew A, Chrispal A, David T. Acute myocardial injury and
rhabdomyolysis caused by multiple bee stings. J Assoc Physi-
cians India 2011; 59: 518-520.
84. Vetter RS, Visscher PK, S. Camazine S. Mass envenoma-
tions by honey bees and wasps. West J Med 1999; 170(4):
223-227.
85. Bartels SA, VanRooyen MJ. Medical complications associat-
ed with earthquakes. Lancet 2012; 379(9817): 748-757.
86. Stollwerck PL, Namdar T, Stang FH, Lange T, Mailänder P,
Siemers F. Rhabdomyolysis and acute renal failure in severe-
ly burned patients. Burns 2011; 37(2): 240-248.
87. Brncic N, Viskovic I, Sasso A, Kraus I, Zamolo G. Salmonella
infection-associated acute rhabdomyolysis. Some pathogenic
considerations. Arch Med Res 2002; 33(3): 313-315
88. Friedman BI, Libby R. Epstein-Barr virus infection associated
with rhabdomyolysis and acute renal failure. Clin Pediatr (Phi-
la) 1986; 25(4): 228-229.
89. Campistol JM, Perez Villa F, Montoliu J, Moreno A, Revert L.
Rhabdomyolysis and acute renal failure associated with Salmo-
nella enteritidis infection. J Hosp Infect 1989; 14(3): 267-268.
90. Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. Rhab-
domyolysis associated with 2009 influenza A(H1N1). JAMA
2009; 302(17): 1863-1864.
91. Chen SC, Liu KS, Chang HR, Lee YT, Chen CC, Lee MC.
Rhabdomyolysis following pandemic influenza A (H1N1) in-
fection. Neth J Med 2010; 68(1): 317-319.
92. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis:
three case reports and review. Clin Infect Dis 1996; 22(4): 642-
649.
93. Medarov BI, Multz AS, Brown W, et al. West Nile meningoen-
cephalitis and rhabdomyolysis. Lancet Infectious Diseases
2005; 5(1): 2.
94. Kumar AA, Bhaskar E, Palamaner Subash Shantha G,
Swaminathan P, Abraham G. Rhabdomyolysis in community
acquired bacterial sepsis--a retrospective cohort study. PLoS
One 2009; 4(9):e7182.
95. Daher EF, Silva GB Jr, de Abreu KL, et al. Leptospirosis-asso-
ciated acute kidney injury: penicillin at the late stage is still con-
troversial. J Clin Pharm Ther 2011.
96. Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral
myositis. Clin Microbiol Rev 2008; 21(3): 473-494.
97. Mishra SK, Pati SS, Mahanta KC, Mohanty S. Rhabdomyoly-
sis in falciparum malaria--a series of twelve cases (five chil-
dren and seven adults). Trop Doct 2010; 40(2): 87-88.
98. Reynaud F, Mallet L, Lyon A, Rodolfo JM. Rhabdomyolysis
and acute renal failure in Plasmodium falciparum malaria.
Nephrol Dial Transplant 2005; 20(4): 847.
99. Amato AA, Griggs RC. Overview of the muscular dystrophies.
Handb Clin Neurol 2011; 101: 1-9.
100. Liang WC, Nishino I. State of the art in muscle lipid diseases.
Acta Myol 2010; 29(2): 351-356.
101. Elsayed EF, Reilly RF. Rhabdomyolysis: a review, with em-
phasis on the pediatric population. Pediatr Nephrol 2010;
25(1): 7-18.
102. Hannah-Shmouni F, McLeod K, Sirrs S. Recurrent exercise-
induced rhabdomyolysis. CMAJ 2012; 184(4): 426-430.
103. Gurnaney H, Brown A, Litman RS. Malignant hyperthermia
and muscular dystrophies. Anesth Analg 2009; 109(4): 1043-
1048.
Muscles, Ligaments and Tendons Journal 2013; 3 (4): 303-312 311
Rhabdomyolysis. The role of diagnostic and prognostic factors
©
 C
IC
Ed
izi
on
i I
nt
rn
zio
na
li
104. Yen TH, Lai PC, Chen CC, Hsueh S, Huang JY. Renal in-
volvement in patients with polymyositis and dermatomyositis.
Int J Clin Pract 2005; 59(2): 188-193.
105. Al-Ismaili Z, Piccioni M, Zappitelli M. Rhabdomyolysis: patho-
genesis of renal injury and management. Pediatr Nephrol
2011; 26(10): 1781-1788.
106. Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O'Brien
K, Campbell WW. Serum creatine kinase after exercise: draw-
ing the line between physiological response and exertional
rhabdomyolysis. Muscle Nerve 2012; 45(3): 356-362.
107. Sorrentino SA, Kielstein JT, Lukasz A, Sorrentino JN,
Gohrbandt B, Haller H, Schmidt BM. High permeability dialysis
membrane allows effective removal of myoglobin in acute kid-
ney injury resulting from rhabdomyolysis. Crit Care Med 2011;
39(1): 184-186.
108. Rodríguez-Capote K, Balion CM, Hill SA, Cleve R, Yang L, El
Sharif A. Utility of urine myoglobin for the prediction of acute re-
nal failure in patients with suspected rhabdomyolysis: a sys-
tematic review. Clin Chem 2009; 55(12):2190-2197.
109. Walsh S, Fan SL. Visualising rhabdomyolysis. Lancet, 2009;
373(9658):154.
110. Moratalla MB, Braun P, Fornas GM. Importance of MRI in the
diagnosis and treatment of rhabdomyolysis. Eur J Radiol
2008; 65(2): 311-315.
111. Mian AZ, Saito N, Sakai O. Rhabdomyolysis of the head and
neck: computed tomography and magnetic resonance imag-
ing findings. Dentomaxillofac Radiol 2011; 40(6):390-392.
112. Lamminen AE, Hekali PE, Tiula E, Suramo I, Korhola OA.
Acute rhabdomyolysis: evaluation with magnetic resonance
imaging compared with computed tomography and ultra-
sonography. Br J Radiol 1989; 62(736): 326-330.
113. Lim ST, Sohn MH, Jeong HJ, Yim CY. Lithotomy position-re-
lated rhabdomyolysis of gluteus maximus muscles demon-
strated by bone scintigraphy. Clin Nucl Med 2008; 33(1): 58-
60.
114. Zhang L, Fang ZJ, Liu F, Fu P, Tao Y, Li ZY, Song B. Magnet-
ic resonance imaging and magnetic resonance angiography in
severe crush syndrome with consideration of fasciotomy or
amputation: a novel diagnostic tool. Chin Med J (Engl) 2011;
124(13): 2068-2070.
115. Quinlivan R, Jungbluth H. Myopathic causes of exercise intol-
erance with rhabdomyolysis. Dev Med Child Neurol 2012.
116. Tarnopolsky M, Stevens L, MacDonald JR, Rodriguez C, Ma-
honey D, Rush J, Maguire J. Diagnostic utility of a modified
forearm ischemic exercise test and technical issues relevant to
exercise testing. Muscle Nerve 2003; 27(3):  359-366.
117. Litman RS, Rosenberg H. Malignant hyperthermia: update on
susceptibility testing. JAMA 2005; 293(23):2918-2924.
118. Montague BT, Ouellette JR, Buller GK. Retrospective review
of the frequency of ECG changes in hyperkalemia. Clin J Am
Soc Nephrol 2008; 3(2): 324-330.
119. Campbell WC, 1880-1941.II. Canale ST, (S. Terry) III. Beaty,
James H. IV. Operative orthopaedics 11 ed. 2008.
120. Lima RS, da Silva Junior GB, Liborio AB, Daher Ede F. Acute
kidney injury due to rhabdomyolysis. Saudi J Kidney Dis
Transpl 2008; 19(5): 721-729.
121. Boutaud O, Roberts LJ, 2nd. Mechanism-based therapeutic
approaches to rhabdomyolysis-induced renal failure. Free
Radic Biol Med 2011; 51(5):1062-1067.
122. Better OS, Stein JH. Early management of shock and prophy-
laxis of acute renal failure in traumatic rhabdomyolysis. N Engl
J Med 1990; 322(12): 825-829.
123. Liamis G, Milionis HJ, Elisaf M. Pharmacologically-induced
metabolic acidosis: a review. Drug Saf 2010; 33(5): 371-391.
124. Gunal AI, Celiker H, Dogukan A, et al. Early and vigorous fluid
resuscitation prevents acute renal failure in the crush victims of
catastrophic earthquakes. J Am Soc Nephrol 2004;
15(7):1862-1867.
125. Zager RA. Rhabdomyolysis and myohemoglobinuric acute re-
nal failure. Kidney Int 1996; 49(2): 314-326.
126. Odeh M. The role of reperfusion-induced injury in the
pathogenesis of the crush syndrome. N Engl J Med 1991;
324(20):1417-1422.
127. Adiseshiah M, Round JM, Jones DA. Reperfusion injury in
skeletal muscle: a prospective study in patients with acute limb
ischaemia and claudicants treated by revascularization. Br J
Surg 1992; 79(10): 1026-1029.
128. Brown CV, Rhee P, Chan L, Evans K, Demetriades D, Velma-
hos GC. Preventing renal failure in patients with rhabdomyoly-
sis: do bicarbonate and mannitol make a difference? J Trauma
2004; 56(6): 1191-1196.
129. Doi K, Ogawa N, Suzuki E, Noiri E, Fujita T. Mannitol-induced
acute renal failure. Am J Med 2003; 115(7): 593-594.
130. Karajala V, Mansour W, Kellum JA. Diuretics in acute kidney
injury. Minerva Anestesiol 2009; 75(5): 251-257.
131. Ho AM, Karmakar MK, Contardi LH, Ng SS, Hewson JR. Ex-
cessive use of normal saline in managing traumatized patients
in shock: a preventable contributor to acidosis. J Trauma 2001;
51(1): 173-177.
132. Antoon JW, Chakraborti C. Corticosteroids in the treatment of
alcohol-induced rhabdomyolysis. Mayo Clin Proc 2011;
86(10): 1005-1007.
Muscles, Ligaments and Tendons Journal 2013; 3 (4): 303-312312
E. Keltz et al.
©
 C
IC
 Ed
izi
on
i I
ter
na
zi
na
li
